FcγR2B B2.4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients.
Costa Neto A, Santos F, Ribeiro I, Oliveira V, Dezan M, Kashima S, Covas D, Pereira A, Fonseca G, Moreira F, Krieger J, Gualandro S, Rocha V, Mendrone A Jr, Dinardo CL.
Costa Neto A, et al. Among authors: krieger j.
Transfusion. 2020 Jul;60(7):1573-1578. doi: 10.1111/trf.15832. Epub 2020 May 4.
Transfusion. 2020.
PMID: 32681817
Clinical Trial.